array(40) {
  [0]=>
  string(4) "1549"
  ["article_id"]=>
  string(4) "1549"
  [1]=>
  string(76) "GPhC opens consultation on education and training standards for pharmacists "
  ["article_title"]=>
  string(76) "GPhC opens consultation on education and training standards for pharmacists "
  [2]=>
  string(127) "The General Pharmaceutical Council has opened its consultation on the initial education and training standards for pharmacists."
  ["short_description"]=>
  string(127) "The General Pharmaceutical Council has opened its consultation on the initial education and training standards for pharmacists."
  [3]=>
  string(127) "The General Pharmaceutical Council has opened its consultation on the initial education and training standards for pharmacists."
  ["description"]=>
  string(127) "The General Pharmaceutical Council has opened its consultation on the initial education and training standards for pharmacists."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(163) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/gphc-opens-consultation-on-education-and-training-standards-for-pharmacists/20205977.article"
  ["blog_url"]=>
  string(163) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/gphc-opens-consultation-on-education-and-training-standards-for-pharmacists/20205977.article"
  [15]=>
  string(19) "2019-01-09 23:30:00"
  ["add_date"]=>
  string(19) "2019-01-09 23:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:21"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1550"
  ["article_id"]=>
  string(4) "1550"
  [1]=>
  string(96) "Pharmacists working with primary care networks are 'best placed' in a community setting "
  ["article_title"]=>
  string(96) "Pharmacists working with primary care networks are 'best placed' in a community setting "
  [2]=>
  string(163) "Pharmacists working with primary care networks, as set out in the ‘NHS Long-Term Plan’, should keep working from their pharmacy rather than from"
  ["short_description"]=>
  string(163) "Pharmacists working with primary care networks, as set out in the ‘NHS Long-Term Plan’, should keep working from their pharmacy rather than from"
  [3]=>
  string(245) "Pharmacists working with primary care networks, as set out in the ‘NHS Long-Term Plan’, should keep working from their pharmacy rather than from a GP surgery, the president of the National Association of Primary Care has said."
  ["description"]=>
  string(245) "Pharmacists working with primary care networks, as set out in the ‘NHS Long-Term Plan’, should keep working from their pharmacy rather than from a GP surgery, the president of the National Association of Primary Care has said."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(164) "https://www.pharmaceutical-journal.com/news-and-analysis/news/pharmacists-working-with-primary-care-networks-are-best-placed-in-a-community-setting/20205979.article"
  ["blog_url"]=>
  string(164) "https://www.pharmaceutical-journal.com/news-and-analysis/news/pharmacists-working-with-primary-care-networks-are-best-placed-in-a-community-setting/20205979.article"
  [15]=>
  string(19) "2019-01-09 23:08:00"
  ["add_date"]=>
  string(19) "2019-01-09 23:08:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:21"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1555"
  ["article_id"]=>
  string(4) "1555"
  [1]=>
  string(40) "Discussing the MMR vaccine with patients"
  ["article_title"]=>
  string(40) "Discussing the MMR vaccine with patients"
  [2]=>
  string(164) "As outlined in Public Health England’s ‘UK Measles and Rubella elimination strategy’, MMR vaccination needs to improve to achieve and maintain e"
  ["short_description"]=>
  string(164) "As outlined in Public Health England’s ‘UK Measles and Rubella elimination strategy’, MMR vaccination needs to improve to achieve and maintain e"
  [3]=>
  string(243) "As outlined in Public Health England’s ‘UK Measles and Rubella elimination strategy’, MMR vaccination needs to improve to achieve and maintain elimination in line with recommendations from the World Health Organization. "
  ["description"]=>
  string(243) "As outlined in Public Health England’s ‘UK Measles and Rubella elimination strategy’, MMR vaccination needs to improve to achieve and maintain elimination in line with recommendations from the World Health Organization. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "12"
  ["rss_id"]=>
  string(2) "12"
  [14]=>
  string(122) "https://www.pharmaceutical-journal.com/learning/learning-article/discussing-the-mmr-vaccine-with-patients/20205819.article"
  ["blog_url"]=>
  string(122) "https://www.pharmaceutical-journal.com/learning/learning-article/discussing-the-mmr-vaccine-with-patients/20205819.article"
  [15]=>
  string(19) "2019-01-09 22:03:00"
  ["add_date"]=>
  string(19) "2019-01-09 22:03:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:22"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "5618"
  ["article_id"]=>
  string(4) "5618"
  [1]=>
  string(63) "IDF World Diabetes Congress 2019 Busan, Korea 2-6 December 2019"
  ["article_title"]=>
  string(63) "IDF World Diabetes Congress 2019 Busan, Korea 2-6 December 2019"
  [2]=>
  string(150) "IDF 2019 in Busan will provide a unique forum for knowledge exchange and sharing of best practice in diabetes prevention, education and treatment, hel"
  ["short_description"]=>
  string(150) "IDF 2019 in Busan will provide a unique forum for knowledge exchange and sharing of best practice in diabetes prevention, education and treatment, hel"
  [3]=>
  string(503) "IDF 2019 in Busan will provide a unique forum for knowledge exchange and sharing of best practice in diabetes prevention, education and treatment, helping to foster the collaborations, connections and political breakthroughs that are required to reduce the impact of diabetes on our societies.&#nlThe IDF 2019 scientific programme will deliver 160 hours of scientific sessions, 300 speakers and 1000 posters, over 3 and a half days. With innovative and interactive sessions, the programme will provid..."
  ["description"]=>
  string(503) "IDF 2019 in Busan will provide a unique forum for knowledge exchange and sharing of best practice in diabetes prevention, education and treatment, helping to foster the collaborations, connections and political breakthroughs that are required to reduce the impact of diabetes on our societies.&#nlThe IDF 2019 scientific programme will deliver 160 hours of scientific sessions, 300 speakers and 1000 posters, over 3 and a half days. With innovative and interactive sessions, the programme will provid..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(94) "https://www.pharmiweb.com/event/idf-world-diabetes-congress-2019-busan-korea-2-6-december-2019"
  ["blog_url"]=>
  string(94) "https://www.pharmiweb.com/event/idf-world-diabetes-congress-2019-busan-korea-2-6-december-2019"
  [15]=>
  string(19) "2019-01-09 18:51:05"
  ["add_date"]=>
  string(19) "2019-01-09 18:51:05"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-11-06 14:38:59"
  ["create_at"]=>
  string(19) "2019-11-06 14:38:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4516"
  ["article_id"]=>
  string(4) "4516"
  [1]=>
  string(51) "GDPR and Implications on Drug Development - Webinar"
  ["article_title"]=>
  string(51) "GDPR and Implications on Drug Development - Webinar"
  [2]=>
  string(156) "Course overview&#nl&#nlThe General Data Protection Regulation (GDPR) came into force on 25 May 2018 and brought substantial changes to the rules around pers"
  ["short_description"]=>
  string(156) "Course overview&#nl&#nlThe General Data Protection Regulation (GDPR) came into force on 25 May 2018 and brought substantial changes to the rules around pers"
  [3]=>
  string(512) "Course overview&#nl&#nlThe General Data Protection Regulation (GDPR) came into force on 25 May 2018 and brought substantial changes to the rules around personal data and its use. Most companies have implemented the requirements, such as creating records for personal data processing activities and preparing data protection assessments.&#nl&#nlHowever, while the GDPR built on existing data protection legislation, it represented a significant change for organisations that hold and process personal data incl..."
  ["description"]=>
  string(512) "Course overview&#nl&#nlThe General Data Protection Regulation (GDPR) came into force on 25 May 2018 and brought substantial changes to the rules around personal data and its use. Most companies have implemented the requirements, such as creating records for personal data processing activities and preparing data protection assessments.&#nl&#nlHowever, while the GDPR built on existing data protection legislation, it represented a significant change for organisations that hold and process personal data incl..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(81) "https://www.pharmiweb.com/event/gdpr-and-implications-on-drug-development-webinar"
  ["blog_url"]=>
  string(81) "https://www.pharmiweb.com/event/gdpr-and-implications-on-drug-development-webinar"
  [15]=>
  string(19) "2019-01-09 18:45:00"
  ["add_date"]=>
  string(19) "2019-01-09 18:45:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:32:21"
  ["create_at"]=>
  string(19) "2019-09-14 14:32:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4529"
  ["article_id"]=>
  string(4) "4529"
  [1]=>
  string(41) "Biotechnology for the Non-Biotechnologist"
  ["article_title"]=>
  string(41) "Biotechnology for the Non-Biotechnologist"
  [2]=>
  string(156) "Course overview&#nl&#nlThis intensive three-day course is ideal for non-scientists and scientists needing to understand the basic theory, principles, techni"
  ["short_description"]=>
  string(156) "Course overview&#nl&#nlThis intensive three-day course is ideal for non-scientists and scientists needing to understand the basic theory, principles, techni"
  [3]=>
  string(512) "Course overview&#nl&#nlThis intensive three-day course is ideal for non-scientists and scientists needing to understand the basic theory, principles, techniques and potential of biotechnology.&#nl&#nlYou will gain an overview of how biotech products are being developed and manufactured, and discuss the scientific and regulatory environment. The latest advances in regulation will be covered, including biosimilars and advanced therapies. The course will also discuss the role and importance of patents withi..."
  ["description"]=>
  string(512) "Course overview&#nl&#nlThis intensive three-day course is ideal for non-scientists and scientists needing to understand the basic theory, principles, techniques and potential of biotechnology.&#nl&#nlYou will gain an overview of how biotech products are being developed and manufactured, and discuss the scientific and regulatory environment. The latest advances in regulation will be covered, including biosimilars and advanced therapies. The course will also discuss the role and importance of patents withi..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(75) "https://www.pharmiweb.com/event/biotechnology-for-the-non-biotechnologist-1"
  ["blog_url"]=>
  string(75) "https://www.pharmiweb.com/event/biotechnology-for-the-non-biotechnologist-1"
  [15]=>
  string(19) "2019-01-09 18:35:41"
  ["add_date"]=>
  string(19) "2019-01-09 18:35:41"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:32:21"
  ["create_at"]=>
  string(19) "2019-09-14 14:32:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1551"
  ["article_id"]=>
  string(4) "1551"
  [1]=>
  string(76) "Government publishes additional no-deal Brexit medicines regulation guidance"
  ["article_title"]=>
  string(76) "Government publishes additional no-deal Brexit medicines regulation guidance"
  [2]=>
  string(150) "More information on how medicines, medical devices and clinical trials would be regulated following a no-deal Brexit has been issued by the Department"
  ["short_description"]=>
  string(150) "More information on how medicines, medical devices and clinical trials would be regulated following a no-deal Brexit has been issued by the Department"
  [3]=>
  string(177) "More information on how medicines, medical devices and clinical trials would be regulated following a no-deal Brexit has been issued by the Department of Health and Social Care."
  ["description"]=>
  string(177) "More information on how medicines, medical devices and clinical trials would be regulated following a no-deal Brexit has been issued by the Department of Health and Social Care."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(164) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/government-publishes-additional-no-deal-brexit-medicines-regulation-guidance/20205971.article"
  ["blog_url"]=>
  string(164) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/government-publishes-additional-no-deal-brexit-medicines-regulation-guidance/20205971.article"
  [15]=>
  string(19) "2019-01-09 17:38:00"
  ["add_date"]=>
  string(19) "2019-01-09 17:38:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:21"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "5312"
  ["article_id"]=>
  string(4) "5312"
  [1]=>
  string(41) "Global Neuroscience and Dementia Research"
  ["article_title"]=>
  string(41) "Global Neuroscience and Dementia Research"
  [2]=>
  string(158) "It gives us great pleasure to warmly welcome you all to “Global Neuroscience and Dementia Research” which will be held in London,UK,Europe during "
  ["short_description"]=>
  string(158) "It gives us great pleasure to warmly welcome you all to “Global Neuroscience and Dementia Research” which will be held in London,UK,Europe during "
  [3]=>
  string(531) "It gives us great pleasure to warmly welcome you all to “Global Neuroscience and Dementia Research” which will be held in London,UK,Europe during Nov 11-12, 2019.The conference is a highly organized campaign with the theme “Global Neuroscience and Dementia Research” which will be the best stage for all the Scientists, Professor’s, Scholars and Clinical Research Organizations to gather on a single platform that helps to gain knowledge from current issues and innovations in the field of Neurosc..."
  ["description"]=>
  string(531) "It gives us great pleasure to warmly welcome you all to “Global Neuroscience and Dementia Research” which will be held in London,UK,Europe during Nov 11-12, 2019.The conference is a highly organized campaign with the theme “Global Neuroscience and Dementia Research” which will be the best stage for all the Scientists, Professor’s, Scholars and Clinical Research Organizations to gather on a single platform that helps to gain knowledge from current issues and innovations in the field of Neurosc..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(73) "https://www.pharmiweb.com/event/global-neuroscience-and-dementia-research"
  ["blog_url"]=>
  string(73) "https://www.pharmiweb.com/event/global-neuroscience-and-dementia-research"
  [15]=>
  string(19) "2019-01-09 09:16:54"
  ["add_date"]=>
  string(19) "2019-01-09 09:16:54"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:28"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:28"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1572"
  ["article_id"]=>
  string(4) "1572"
  [1]=>
  string(51) "Sandoz Subsidiary Called Out for Contamination Risk"
  ["article_title"]=>
  string(51) "Sandoz Subsidiary Called Out for Contamination Risk"
  [2]=>
  string(158) "&#nl        The FDA cited Fougera Pharmaceuticals’ facility in Hicksville, New York, serving the Sandoz subsidiary a Form 483 for failing to follow pro"
  ["short_description"]=>
  string(158) "&#nl        The FDA cited Fougera Pharmaceuticals’ facility in Hicksville, New York, serving the Sandoz subsidiary a Form 483 for failing to follow pro"
  [3]=>
  string(231) "&#nl        The FDA cited Fougera Pharmaceuticals’ facility in Hicksville, New York, serving the Sandoz subsidiary a Form 483 for failing to follow procedures designed to prevent contamination of its drug products.&#nl      "
  ["description"]=>
  string(231) "&#nl        The FDA cited Fougera Pharmaceuticals’ facility in Hicksville, New York, serving the Sandoz subsidiary a Form 483 for failing to follow procedures designed to prevent contamination of its drug products.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(91) "https://www.fdanews.com/articles/189797-sandoz-subsidiary-called-out-for-contamination-risk"
  ["blog_url"]=>
  string(91) "https://www.fdanews.com/articles/189797-sandoz-subsidiary-called-out-for-contamination-risk"
  [15]=>
  string(19) "2019-01-09 07:29:33"
  ["add_date"]=>
  string(19) "2019-01-09 07:29:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:24"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1573"
  ["article_id"]=>
  string(4) "1573"
  [1]=>
  string(53) "Opioid Companies, Distributors Seek Gag Order in Ohio"
  ["article_title"]=>
  string(53) "Opioid Companies, Distributors Seek Gag Order in Ohio"
  [2]=>
  string(153) "&#nl        A group of opioid manufacturers and distributors filed for a gag order against Ohio Attorney General Mike DeWine and two other prominent atto"
  ["short_description"]=>
  string(153) "&#nl        A group of opioid manufacturers and distributors filed for a gag order against Ohio Attorney General Mike DeWine and two other prominent atto"
  [3]=>
  string(220) "&#nl        A group of opioid manufacturers and distributors filed for a gag order against Ohio Attorney General Mike DeWine and two other prominent attorneys in connection with multidistrict opioid litigation.&#nl      "
  ["description"]=>
  string(220) "&#nl        A group of opioid manufacturers and distributors filed for a gag order against Ohio Attorney General Mike DeWine and two other prominent attorneys in connection with multidistrict opioid litigation.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(92) "https://www.fdanews.com/articles/189796-opioid-companies-distributors-seek-gag-order-in-ohio"
  ["blog_url"]=>
  string(92) "https://www.fdanews.com/articles/189796-opioid-companies-distributors-seek-gag-order-in-ohio"
  [15]=>
  string(19) "2019-01-09 07:28:45"
  ["add_date"]=>
  string(19) "2019-01-09 07:28:45"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:24"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1557"
  ["article_id"]=>
  string(4) "1557"
  [1]=>
  string(51) "Lawsuit: Walmart, Drugmaker Sold Contaminated Drugs"
  ["article_title"]=>
  string(51) "Lawsuit: Walmart, Drugmaker Sold Contaminated Drugs"
  [2]=>
  string(153) "&#nl        A Florida class-action suit charges Walmart, Aurobindo Pharma, ScieGen Pharmaceuticals and Westminster Pharmaceuticals negligently allowed po"
  ["short_description"]=>
  string(153) "&#nl        A Florida class-action suit charges Walmart, Aurobindo Pharma, ScieGen Pharmaceuticals and Westminster Pharmaceuticals negligently allowed po"
  [3]=>
  string(223) "&#nl        A Florida class-action suit charges Walmart, Aurobindo Pharma, ScieGen Pharmaceuticals and Westminster Pharmaceuticals negligently allowed potentially carcinogenic blood pressure drugs onto the market.&#nl      "
  ["description"]=>
  string(223) "&#nl        A Florida class-action suit charges Walmart, Aurobindo Pharma, ScieGen Pharmaceuticals and Westminster Pharmaceuticals negligently allowed potentially carcinogenic blood pressure drugs onto the market.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "14"
  ["rss_id"]=>
  string(2) "14"
  [14]=>
  string(89) "https://www.fdanews.com/articles/189786-lawsuit-walmart-drugmaker-sold-contaminated-drugs"
  ["blog_url"]=>
  string(89) "https://www.fdanews.com/articles/189786-lawsuit-walmart-drugmaker-sold-contaminated-drugs"
  [15]=>
  string(19) "2019-01-09 06:34:06"
  ["add_date"]=>
  string(19) "2019-01-09 06:34:06"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:23"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:23"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1552"
  ["article_id"]=>
  string(4) "1552"
  [1]=>
  string(79) "NHS England to pilot patient referral scheme between GPs and community pharmacy"
  ["article_title"]=>
  string(79) "NHS England to pilot patient referral scheme between GPs and community pharmacy"
  [2]=>
  string(150) "NHS England is set to pilot a scheme that will see GPs refer patients to community pharmacy, the chief pharmaceutical officer for England has revealed"
  ["short_description"]=>
  string(150) "NHS England is set to pilot a scheme that will see GPs refer patients to community pharmacy, the chief pharmaceutical officer for England has revealed"
  [3]=>
  string(151) "NHS England is set to pilot a scheme that will see GPs refer patients to community pharmacy, the chief pharmaceutical officer for England has revealed."
  ["description"]=>
  string(151) "NHS England is set to pilot a scheme that will see GPs refer patients to community pharmacy, the chief pharmaceutical officer for England has revealed."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(158) "https://www.pharmaceutical-journal.com/news-and-analysis/news/nhs-england-to-pilot-patient-referral-scheme-between-gps-and-community-pharmacy/20205975.article"
  ["blog_url"]=>
  string(158) "https://www.pharmaceutical-journal.com/news-and-analysis/news/nhs-england-to-pilot-patient-referral-scheme-between-gps-and-community-pharmacy/20205975.article"
  [15]=>
  string(19) "2019-01-09 01:24:00"
  ["add_date"]=>
  string(19) "2019-01-09 01:24:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:21"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}